comparemela.com

Ablaze Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China

/PRNewswire/ Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today.

Zhi yangSan diegoUnited statesAlex qiaoRadiopharmaceutical society of chinese nuclearRayzebio incAblaze pharmaceuticalsNuclear medicine at beijing cancer hospitalPrnewswire ablaze pharmaceuticalsGreater chinaNuclear medicineBeijing cancer hospitalFounding presidentRadiopharmaceutical societyChinese nuclearChief executive officer

Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies

/PRNewswire/ In July 2022, Ablaze Pharma and Wenjiang District Government of Chengdu jointly signed the strategic agreement during the Conference of Major.

Li zhangAlex qiaoRadioisotope engineering technology research centerNational engineering research centerInvestment promotion bureauRadioisotope and drug rd centerAblaze pharmaceuticalsManagement committeeAblaze pharmaWenjiang district governmentMajor advanced manufacturing projectsForeign directChengdu medical cityWenjiang districtSichuan provinceChengdu medical

vimarsana © 2020. All Rights Reserved.